T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 1,677 | 1,804 | 1,785 | 1,792 | 2,466 |
| Cost of Goods | 3,944 | 4,820 | 4,388 | 5,631 | 3,042 |
| Gross Profit | -2,267 | -3,016 | -2,603 | -3,839 | -576 |
| Operating Expenses | 11,023 | 11,590 | 11,344 | 10,386 | 8,640 |
| Operating Income | -12,346 | -13,786 | -13,559 | -13,594 | -9,174 |
| Interest Expense | 1,876 | 2,000 | 1,782 | 1,772 | 1,836 |
| Other Income | 51 | 139 | 194 | 217 | 243 |
| Pre-tax Income | -14,171 | -15,647 | -15,147 | -15,149 | -10,767 |
| Net Income Continuous | -14,171 | -15,647 | -15,147 | -15,149 | -10,767 |
| Net Income | $-14,171 | $-15,647 | $-15,147 | $-15,149 | $-10,767 |
| EPS Basic Total Ops | -1,550.00 | -1,750.00 | -1,700.00 | -1,650.00 | -1,250.00 |
| EPS Basic Continuous Ops | -1,560.24 | -1,761.02 | -1,710.29 | -1,670.85 | -1,230.15 |
| EPS Diluted Total Ops | -1,550.00 | -1,750.00 | -1,700.00 | -1,650.00 | -1,250.00 |
| EPS Diluted Continuous Ops | -1,560.24 | -1,761.02 | -1,710.29 | -1,670.85 | -1,230.15 |
| EBITDA(a) | $-10,759 | $-13,513 | $-12,660 | $-13,007 | $-8,536 |